The overexpression of tumor-specific peptide receptors—such as the gastrin-releasing peptide receptor, natriuretic peptide receptor, and somatostatin receptor—in cancer cells offers an ideal molecular basis for targeted imaging and therapeutic approaches. Here, GRPR is linked to cancer.